Abstract:There is growing awareness of reproducibility concerns within the scientific literature; whilst journals continue to be filled with seemingly beautiful results, teams of researchers are lifting the lid on the veracity of scientific claims and the replicability of findings in a growing number of disciplines. Highlighting the global scale of this issue, the Open Science Collaboration (<a href="#">2015</a>) performed direct replications of 100 psychological research studies and found that whilst 97% of the original studies reported significant results, this declined to 36% for replications of these. Moreover, the average effect size of the replications was half the magnitude of the average across original studies. Several human decision-making factors have been proposed to underlie irreproducibility, such as selective reporting and questionable research practices (QRPs; Simmons et al. <a href="#">2011</a>; John et al. <a href="#">2012</a>) fueled by pressures to achieve novel, surprising results and incentive structures that reward quantity over quality (Giner-Sorolla <a href="#">2012</a>; Frith <a href="#">2020</a>; Munafò et al. <a href="#">2020</a>). As can be seen in <a href="#F0001">Figure 1</a>, there are many threats that can arise at each stage of the hypothetico-deductive scientific process, which can undermine the robustness of published research and constrain knowledge accumulation. In their 'manifesto for reproducible science', Munafò et al. (<a href="#">2017</a>) propose five measures that target these threats with the goal of improving research: (1) methods, (2) reporting and dissemination, (3) reproducibility, (4) evaluation, and (5) incentives. Adoption of open science practices will allow many of these measures to be achieved and calls for their implementation in addiction science are becoming louder (Heirene <a href="#">2021</a>; Louderback et al. <a href="#">2021</a>; Pennington et al. <a href="#">2021</a>). However, to be successful, academic journals also need to adapt and recentre their focus on scientific rigor rather than the metamorphosis of study results. In this Editorial, we introduce two types of Registered Reports (RRs) that satisfy all these measures and highlight our commitment by offering these publishing tracks to authors through ART. We first outline the 'traditional' RR format (which ART has offered since 2019) and its associated advantages, followed by the introduction of a new initiative launched in April 2021 – Peer Community In Registered Reports (PCI RR).

The Impact of Preclinical Irreproducibility on Drug Development

Decatastrophizing research irreproducibility

When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis

Repetition and reproduction of preclinical medical studies: taking a leaf from the plant sciences with consideration of generalised systematic errors

Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles

Reproducible Research Can Still Be Wrong: Adopting a Prevention Approach

Productivity shortfalls in drug discovery: contributions from the preclinical sciences?

Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity Is Doing the Same Thing Over and Over and Expecting Different Results

Improving reproducibility in animal research

On the reproducibility of science: unique identification of research resources in the biomedical literature

Impact of quality and transparency in scientific writing on the reduction of animal usage in experimental protocols: a review based in pertinent literature

Reproducibility in Preclinical in Vivo Research: Statistical Inferences

Systematic heterogenization for better reproducibility in animal experimentation

Entering the era of computationally driven drug development

Teaching reproducible research for medical students and postgraduate pharmaceutical scientists

Reproducible Research: A Retrospective

Biomedical researchers' perspectives on the reproducibility of research

Digitalization of toxicology: improving preclinical to clinical translation

Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study Examples

Reshaping the publication process: Addiction Research and Theory joins Peer Community In Registered Reports

Evaluating Study Design Rigor in Preclinical Cardiovascular Research: A Replication Study